Category: Associations

SNMMI Reacts to CMS Coverage Decision on New Alzheimer’s Therapy

On Tuesday, January 11, the Centers for Medicare and Medicaid Services (CMS) announced that it proposes to cover U.S. FDA-approved monoclonal antibodies directed against amyloid for the treatment of Alzheimer’s disease under Coverage with Evidence Development in CMS-approved randomized controlled trials. Here is the SNMMI’s reaction.

Read More

MITA Applauds NIST Update to Consumer Software Definition

The Medical Imaging & Technology Alliance (MITA) has submitted comments to the National Institute for Standards and Technology (NIST) requesting clarification of its definition of consumer IoT products to distinguish it from non-consumer products in its recent draft document, “Consumer Cybersecurity Labeling for IoT Products—Discussion Draft on the Path Forward.”

Read More
Loading